nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Burden of rheumatoid arthritis and forecasted prevalence to 2050
|
Lau, Chak Sing |
|
|
5 |
10 |
p. e567-e568 |
artikel |
2 |
Correction to Lancet Rheumatol 2023; 5: e461–73
|
|
|
|
5 |
10 |
p. e582 |
artikel |
3 |
DAVIX: a vascular outcome measure in systemic sclerosis
|
Kapoor, Puneet |
|
|
5 |
10 |
p. e569-e570 |
artikel |
4 |
Diffuse alveolar haemorrhage during pregnancy in systemic lupus erythematosus
|
Dashraath, Pradip |
|
|
5 |
10 |
p. e637-e638 |
artikel |
5 |
Expanding genetic diversity and polygenic risk scores application in rheumatic disease studies: a call for inclusive research
|
Castro-Santos, Patricia |
|
|
5 |
10 |
p. e572-e574 |
artikel |
6 |
Global, regional, and national burden of rheumatoid arthritis, 1990–2020, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021
|
|
|
|
5 |
10 |
p. e594-e610 |
artikel |
7 |
Gout incidence and management during the COVID-19 pandemic in England, UK: a nationwide observational study using OpenSAFELY
|
Russell, Mark D |
|
|
5 |
10 |
p. e622-e632 |
artikel |
8 |
Impact of low disease activity, remission, and complete remission on flares following tapering of corticosteroids and immunosuppressive therapy in patients with systemic lupus erythematous: a multinational cohort study
|
Cho, Jiacai |
|
|
5 |
10 |
p. e584-e593 |
artikel |
9 |
Large language models and rheumatology: a comparative evaluation
|
Venerito, Vincenzo |
|
|
5 |
10 |
p. e574-e578 |
artikel |
10 |
MRI Digital Artery Volume Index (DAVIX) as a surrogate outcome measure of digital ulcer disease in patients with systemic sclerosis: a prospective cohort study
|
Hughes, Michael |
|
|
5 |
10 |
p. e611-e621 |
artikel |
11 |
Research in Brief
|
Thorley, Jennifer |
|
|
5 |
10 |
p. e583 |
artikel |
12 |
Role of plasma exchange in ANCA-associated vasculitis
|
Pimentel-Quiroz, Victor R |
|
|
5 |
10 |
p. e579-e580 |
artikel |
13 |
Role of plasma exchange in ANCA-associated vasculitis – Authors' reply
|
Magri, Sebastián Juan |
|
|
5 |
10 |
p. e580-e581 |
artikel |
14 |
Tapering or discontinuing SLE treatments: when and how?
|
Nguyen, Yann |
|
|
5 |
10 |
p. e566-e567 |
artikel |
15 |
Technology, COVID-19, and approaching the insoluble problems of gout care
|
Jatuworapruk, Kanon |
|
|
5 |
10 |
p. e570-e571 |
artikel |
16 |
The painful truth of gout in the UK
|
The Lancet Rheumatology, |
|
|
5 |
10 |
p. e565 |
artikel |
17 |
Unintentional unblinding in rheumatic disease trials
|
Bruggemeyer, Cody |
|
|
5 |
10 |
p. e633-e636 |
artikel |